Short Interest in Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) Grows By 300.0%

Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) saw a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 400,000 shares, an increase of 300.0% from the February 28th total of 100,000 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily volume of 23,757,600 shares, the short-interest ratio is presently 0.0 days.

Endonovo Therapeutics Trading Down 50.0 %

Shares of ENDV stock opened at $0.00 on Friday. Endonovo Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.00.

Endonovo Therapeutics Company Profile

Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.